Middle East Archives - Kybora

Home
About Us
Services
News Feed
Contact

Home
About Us
Services
News Feed
Contact

Riyadh

September 21, 2020

Comments are off for this post.

Recent blog post.

KYBORA is happy to announce that Khai Meng Ang has joined its team as Senior Advisor for China.

Posted: 2 days ago
KYBORA is pleased to announce that its client Megalabs has acquired acquired Fr!ska.

Posted: 5 days ago
KYBORA is pleased to announce the licensing of Daewoong’s development stage IPF therapy (Bersiporocin) to CS Pharmaceuticals for the Greater China region.

Posted: 5 days ago
KYBORA is pleased to announce that its trademarks have been approved and registered by the Chinese government.

Posted: 8 months ago
KYBORA is pleased to announce the partnering of ORLADEYO® (berotralstat) in Latin America.

Posted: 8 months ago

Tags.

#biopharma Licensing Announcement Bausch Health biopharma biotechnology China Conference Corporate globalhealthcare healthtech Kybora Team LIcensing March 2020 mergersandacquisitions News Priority List Stada license

How can we help you succeed?

We want to learn more about your strategic, fundraising, business, and corporate development needs.

Tell us about your needs!

Kybora is a global advisory firm whose mission is to help life sciences companies achieve enduring success by offering optimal M&A, licensing, fundraising and strategic consulting services in all key markets around the world.

Pages.

About Kybora
Our Sectors
Our Team
Global Presence

Success Stories
News Feed
Contact Us

Recent blog post.

KYBORA is happy to announce that Khai Meng Ang has joined its team as Senior Advisor for China.

Posted: 2 days ago
KYBORA is pleased to announce that its client Megalabs has acquired acquired Fr!ska.

Posted: 5 days ago
KYBORA is pleased to announce the licensing of Daewoong’s development stage IPF therapy (Bersiporocin) to CS Pharmaceuticals for the Greater China region.

Posted: 5 days ago

© KYBORA All Rights Reserved.

Terms of service | Privacy policy

TYPE & ENTER: